SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form 20-F/A - Annual and transition report of foreign private issuers [Sections 13 or 15(d)]: [Amend]
SEC Accession No. 0001213900-19-005687
Filing Date
2019-04-03
Accepted
2019-04-03 07:38:56
Documents
6
Period of Report
2018-12-31

Document Format Files

Seq Description Document Type Size
1 AMENDMENT NO. 1 TO FORM 20-F f20f2018a1_kitovpharmaltd.htm 20-F/A 71071
2 PRODUCT MANUFACTURING AGREEMENT, EFFECTIVE AS OF NOVEMBER 8, 2018, BY AND BETWEE f20f2018a1ex4-15_kitov.htm EX-4.15 155250
3 AGREEMENT DATED AS OF DECEMBER 27, 2018, BY AND BETWEEN KITOV PHARMA LTD. AND CO f20f2018a1ex4-16_kitov.htm EX-4.16 228882
4 STOCK PURCHASE AGREEMENT BY AND AMONG KITOV PHARMA LTD., THE STOCKHOLDERS OF FAM f20f2018a1ex4-17_kitov.htm EX-4.17 954560
5 CERTIFICATION f20f2018a1ex12-1_kitov.htm EX-12.1 3215
6 CERTIFICATION f20f2018a1ex12-2_kitov.htm EX-12.2 3398
  Complete submission text file 0001213900-19-005687.txt   1417559
Mailing Address ONE AZRIELI CENTER, ROUND TOWER 132 MENACHEM BEGIN ROAD TEL AVIV L3 6701101
Business Address ONE AZRIELI CENTER, ROUND TOWER 132 MENACHEM BEGIN ROAD TEL AVIV L3 6701101 97239333121
Kitov Pharma Ltd. (Filer) CIK: 0001614744 (see all company filings)

IRS No.: 000000000 | State of Incorp.: L3 | Fiscal Year End: 1231
Type: 20-F/A | Act: 34 | File No.: 001-37643 | Film No.: 19727493
SIC: 2834 Pharmaceutical Preparations
Assistant Director 1